Evidence map›Paper›PMID 42420774›Full record

ArticleBioFactors (Oxford, England)

A Di-Rhamnolipid (Rha

Sultan Pulat, Prima F Hillman, Jaeyoung Ko, Sang-Jip Nam, Hangun Kim

Abstract read
In one paragraph

Article in BioFactors (Oxford, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sultan PulatCollege of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Jeonnam, Republic of Korea.ORCID https://orcid.org/0000-0001-9871-8296
Prima F HillmanDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Andalas, Padang, Indonesia.
Jaeyoung KoAmorepacific Corporation R&D Center, Yongin, Republic of Korea.
Sang-Jip NamDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea.
Hangun KimCollege of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Jeonnam, Republic of Korea.ORCID https://orcid.org/0000-0001-5889-8907

Funding

Korea Government (MSIT) RS-2024-00413760Ministry of Oceans and Fisheries 20200297
6 · The paper itself

Abstract

Colorectal cancer (CRC) progression is driven by metastatic potential, metabolic reprogramming, and immune evasion. In this study, we investigated the effects of a di-rhamnolipid, Rha

Indexed as

B7-H1 AntigenColorectal NeoplasmsGlycolipidsProto-Oncogene Proteins c-aktCaco-2 CellsCell Line, TumorCell MovementGene Expression Regulation, NeoplasticHeterocyclic Compounds, 3-RingHumansImmune EvasionSignal TransductionB7-H1 AntigenCD274 protein, humanGlycolipidsHeterocyclic Compounds, 3-RingMK 2206Proto-Oncogene Proteins c-aktAKTglycolysisimmune evasionmetastasisPD‐L1rhamnolipids

Identifiers

PMID42420774
PMCPMC13513952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.